Sublinguals

A diverse range of oral solutions designed for flexible and patient-friendly administration.

Quality-focused oral suspension formulations supporting diverse therapeutic applications and patient needs.

Pellet-based dosage forms offering flexible solutions for diverse pharmaceutical applications.

Convenient and patient-focused delivery formats designed for modern pharmaceutical needs.

Polymer chemistry capabilities supporting diverse pharmaceutical applications through strong expertise, quality and scalable solutions.

Reliable solid support systems backed by strong chemistry expertise and capabilities for complex molecule development.

A broad range of syrup formulations developed to support diverse patient and therapeutic needs.

A comprehensive tablet portfolio spanning diverse therapeutic categories and patient needs.

A versatile portfolio of vial-based products supported by reliable manufacturing and quality standards.

API

Growing capabilities in complex peptides, combining advanced expertise, quality-focused processes and reliable support for pharmaceutical partners

Specialized capabilities in iron complexes, supported by strong chemistry expertise and a commitment to quality and reliable supply.

MSN Group is one of the fastest-growing, research-based and fully integrated pharmaceutical companies based out of Hyderabad, India. It was founded in the year 2003 with a mission to make high-quality medicines affordable and accessible to the world. The organization presently has 24 state-of-the-art manufacturing facilities (16 API and 8 Finished Dosage Facilities) established across India and USA. The group has an integrated R&D centre that facilitates the research of both API and Finished Dosages under one roof, enabling the organization to introduce new and affordable therapies in global markets swiftly.